Failure to transfer multiple sclerosis into severe combined immunodeficiency mice by mononuclear cells from CSF of

Q Hao1, T Saida, M Nishimura

  • 1Department of Neurology, Utano National Hospital, Kyoto, Japan.

Neurology
|January 1, 1994
PubMed

Insights

Researchers attempted to reproduce findings that multiple sclerosis (MS) is transferable via cerebrospinal fluid (CSF) cells. However, injecting MS patient CSF cells into mice did not cause disease, failing to confirm the previous reports.

Area of Science:

  • Neuroimmunology
  • Experimental Neurology
  • Cellular Pathology

Background:

  • Previous studies suggested that multiple sclerosis (MS) may be transferable through cerebrospinal fluid (CSF) cells.
  • Confirmation of this transmission mechanism is crucial for understanding MS pathogenesis.

Purpose of the Study:

  • To investigate the reproducibility of MS transfer via CSF cells.
  • To determine if CSF cells from MS patients in exacerbation can induce disease in an immunodeficient model.

Main Methods:

  • Cerebrospinal fluid (CSF) cells were collected from six patients with active multiple sclerosis (MS).
  • These cells were injected into the cisterna magna of 18 severe combined immunodeficiency (SCID) mice.
  • Mice were monitored for clinical signs of neurologic disease and analyzed pathologically.

Main Results:

  • No clinical neurologic abnormalities were observed in any of the recipient mice.
  • Light and electron microscopic examination revealed no pathological changes indicative of MS.
  • The previously reported transfer of MS via CSF cells could not be reproduced in this study.

Conclusions:

  • The findings do not support the hypothesis that multiple sclerosis (MS) is transferable by cerebrospinal fluid (CSF) cells.
  • The inability to reproduce the reported results suggests potential issues with the original methodology or interpretation.
  • Further research is needed to elucidate the mechanisms of MS pathogenesis and potential transmission routes.

Related Concept Videos